Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma

M Sensi1, G Nicolini, C Petti

  • 1Human Tumor Immunobiology Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy. marialuisa.sensi@istitutotumori.mi.it

Oncogene
|February 8, 2006
PubMed

Insights

Activating BRAF or NRAS mutations drive melanoma, but typically not together in single cells. NRASQ61R mutations confer distinct growth advantages over BRAFV600E mutations in melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Activating BRAF or NRAS mutations are present in 80% of sporadic melanomas.
  • Typically, only one mutation (BRAF or NRAS) is detected per tumor, suggesting mutual exclusivity.
  • The potential for co-occurrence and functional consequences of BRAF and NRAS mutations in melanoma remain unclear.

Purpose of the Study:

  • To investigate the co-occurrence of BRAF and NRAS mutations in melanoma.
  • To analyze the distinct biological properties associated with BRAF and NRAS mutations.
  • To understand the implications of these mutations on melanoma cell behavior.

Main Methods:

  • Mutant-allele-specific-amplification-PCR was used to detect BRAFV600E and NRASQ61R mutations.
  • Melanoma clones were isolated using soft agar growth.
  • In vitro and in vivo growth assays were performed on isolated clones.

Main Results:

  • One out of 14 short-term melanoma lines harbored both BRAFV600E and NRASQ61R mutations.
  • Analysis of 21 melanoma clones revealed mutually exclusive BRAFV600E and NRASQ61R genotypes at the single-cell level.
  • NRASQ61R clones showed reduced soft agar growth but enhanced proliferation in liquid media and in vivo compared to BRAFV600E clones.

Conclusions:

  • Activating BRAF and NRAS mutations can coexist within a single melanoma but are mutually exclusive at the single-cell level.
  • BRAFV600E and NRASQ61R mutations are associated with distinct in vitro and in vivo growth characteristics.
  • These findings provide insights into melanoma tumorigenesis and the differential roles of BRAF and NRAS mutations.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...